Comparative Study on Overexpression of HER2/neu and HER3 in Gastric Cancer

Xiu Zhang; Yun Yang; Dong Xu; Jian Qu; Ming Guo; Yan Gong; Jin Huang
October 2009
World Journal of Surgery;Oct2009, Vol. 33 Issue 10, p2112
Academic Journal
Owing to the special importance of the HER family in tumorigenesis, the downstream signaling pathways and effectors have become the key molecules in the strategy of carcinoma-targeted therapy. Recent evidence that HER3 is responsible for tumor resistance to therapeutic agents targeting EGFR or HER2/neu, along with the new findings that HER3 is involved in the process of dedifferentiation of gastric cancer (GC) have highlighted the critical role of HER3 in cancer research. HER3 is becoming a new targeted molecule in cancer treatment. Here, we comparatively investigated the expression of HER2/neu and HER3 in gastric cancer of two pathologic types (intestinal type and diffuse type) using immunohistochemistry (IHC) and analyzed the correlation between overexpression of HER2 and HER3 and clinicopathologic parameters. An IHC study for HER2 and HER3 was performed on 102 formalin-fixed, paraffin-embedded specimens of GC—60 intestinal and 42 diffuse types. The correlation between overexpression of HER2 and HER3 and clinicopathologic parameters was statistically analyzed. In the GC group, overexpression of HER2 and HER3 was detected in 19 (18.6%) and 14 (13.7%) of 102 GC patients, respectively. In a nontumorous group of 102 specimens, 5 were HER2-positive (4.9%) (18.6% vs. 4.9%, p < 0.01), and 2 were HER3-positive (2.0%) (13.7% vs. 2.0%, p < 0.01). No co-overexpression of HER2 and HER3 was observed. The intestinal type of GC exhibited a higher rate of HER2 overexpression than did the diffuse type (26.7% vs. 7.1%, p < 0.05), whereas the diffuse type of GC exhibited a significantly higher rate of HER3 overexpression than did the intestinal type (26.2% vs. 5.0%, p < 0.01). The overexpression rates of HER2 and HER3 in phase III–IV (TNM stage) disease were significantly higher than that in phase I–II disease (24.0% vs. 7.7%, p < 0.05 and 22.0% vs. 5.8%, p < 0.05, respectively). HER2 and HER3 overexpression was also correlated with a significantly worse survival ( p = 0.046 and 0.024, respectively). The selective overexpression of HER2 and HER3 in the two histologic types of gastric cancer is strongly associated with a poor prognosis. Being an important member of the HER family, HER3 may become another candidate for molecular-targeted therapy in gastric cancer, especially for the diffuse histologic type.


Related Articles

  • Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7. Vang, Russell; Gown, Allen M.; Lee-Shu-Fune Wu; Barry, Todd S.; Wheeler, Darren T.; Yemelyanova, Anna; Seidman, Jeffrey D.; Ronnett, Brigitte M.; Wu, Lee-Shu-Fune // Modern Pathology;Nov2006, Vol. 19 Issue 11, p1421 

    No abstract available.

  • Gastrointestinal stromal tumour of the stomach mimicking a hepatic tumour: a case report. Subasinghe, Duminda; Rathnasena, Bowlanegedara Nimal; Medagodahetti, Udayanga S.; Bhishman, Thevaraj // BMC Research Notes;2014, Vol. 7 Issue 1, p1 

    Background: Gastrointestinal stromal tumours are the commonest mesenchymal tumours of the gastrointestinal tract. The stomach and small intestine are the favoured sites of occurrence. The symptoms of these depend on the site, size of the tumour and may include abdominal pain, gastrointestinal...

  • TUMORES MÃœLLERIANOS MIXTOS DE CUELLO UTERINO. Siebald, Enrique; Puga, Oscar; Madrid, Patricio // Revista Chilena de Obstetricia y Ginecología;2008, Vol. 73 Issue 2, p128 

    Objective: 3 clinical cases of mixed müllerian tumors of uterine cervix and a literature review are presented. Method: Retrospective analysis of clinical charts and pathological reports between november 1997 and january 2005. Results: Patients" ages ranged from 36 to 56 years (mean: 48,3...

  • TUMOR OVÁRICO DE BAJO POTENCIAL MALIGNO (BORDERLINE): PATRÓN SEROSO MICROPAPILAR. C., Patricio Cisterna; H., Ricardo Orellana; H., Andrés Freire // Revista Chilena de Obstetricia y Ginecología;2007, Vol. 72 Issue 4, p241 

    The tumours of low malignant potential or borderline, their clinical importance and the recommended therapeutic approach from the present knowledge are described. The existence of a micropapilar variety, according to some authors, presents a greater frequency of invasive implant and recurrences...

  • Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis. Shuji Kitahara; Yasuhiro Suzuki; Masae Morishima; Asuka Yoshii; Sachiko Kikuta; Kazuhiko Shimizu; Shunichi Morikawa; Yasufumi Sato; Taichi Ezaki1 // Molecular Cancer;2014, Vol. 13 Issue 1, p1 

    Background Vasohibin-2 (VASH2) has been identified as an endogenous and vascular endothelial growth factor (VEGF)-independent angiogenic factor that is highly expressed in tumor cells. In the present study, we aimed to determine whether pre-existing vascular changes can be used to predict tumor...

  • Rapid induction of apoptosis in human gastric cancer cell lines by sorbitol. Teramachi, Kazuki; Izawa, Masao // Apoptosis;Apr2000, Vol. 5 Issue 2, p181 

    Most solid tumors, including gastric cancers, respond poorly to non-surgical treatments which are expected to induce an apoptosis-dependent involution. We hypothesize that the apoptotic machinery in solid tumors is either defective or in a suppressed condition. Overcoming the ineffective...

  • Clinicopathologic Analysis of 4 Perivascular Epithelioid Cell Tumors (PEComas) of the Gastrointestinal Tract. Huai-yin Shi; Li-xin Wei; Lu Sun; Ai-tao Guo // International Journal of Surgical Pathology;Aug2010, Vol. 18 Issue 4, p243 

    This study describes the clinical, histologic, and immunohistochemical features of four cases of GI PEComa. The size of the tumors ranged from 3.5 to 6.0cm in diameter, and all were located in wall of the large bowel. Microscopically, the tumors were characterized by an epithelioid arrangement...

  • Complex Genetic Alterations in Gastrointestinal Stromal Tumors with Autonomic Nerve Differentiation. Debiec-Rychter, Maria; Pauwels, Patrick; Lasota, Jerzy; Franke, Sabine; De Vos, Rita; de Wever, Ivo; Anne3 Hagemeijer; Sciot, Raf // Modern Pathology;Jul2002, Vol. 15 Issue 7, p692 

    Gastrointestinal stromal tumors (GISTs) with neurogenic differentiation, also referred to as "gastrointestinal autonomic nerve tumors (GANTs)," form an ultrastructurally distinctive subgroup of mesenchymal neoplasms of gastrointestinal tract. Cytogenetic and molecular data of these tumors are...

  • Prise en charge nutritionnelle des cancers de la jonction oesogastrique. Flori, N.; Guillaumon, V.; Chrostek, H.; Fouques, L.; Senesse, P. // Oncologie;Mar2013, Vol. 15 Issue 3/4, p169 

    The national recommendations on perioperative guidelines published in 2010 and on Nutrition Cancer in 2012 can now offer a consistent approach to cancer care management, especially in gastrointestinal cancers. As such, cancer of the gastroesophageal junction requires vigilance of all and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics